ACE inhibition and glucose transport in insulinresistant muscle: roles of bradykinin and nitric oxide.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  American Journal of Physiology. Regulatory Integrative and Comparative Physiology

• Publication date

  1999-07-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1152/ajpregu.1999.277.1.R332PMID 10409290
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of chronic bradykinin administration on insulin action in an animal model of insulin resistance.

  1998cited by this paper
• Bradykinin potentiates insulin-stimulated glucose uptake and enhances insulin signal through the bradykinin B2 receptor in dog skeletal muscle and rat L6 myoblasts.

  1998influential reference
• Evidence for altered sensitivity of the nitric oxide/cGMP signalling cascade in insulin-resistant skeletal muscle.

  1998cited by this paper
• Nitric oxide stimulates glucose transport and metabolism in rat skeletal muscle in vitro.

  1997cited by this paper
• Evidence that nitric oxide increases glucose transport in skeletal muscle.

  1997cited by this paper
• Defective endogenous nitric oxide-mediated modulation of cellular respiration in canine skeletal muscle after the development of heart failure.

  1997cited by this paper
• Effect of Captopril, Losartan, and Bradykinin on Early Steps of Insulin Action

  1997influential reference
• Expression of Nitric Oxide Synthase in Skeletal Muscle: A Novel Role for Nitric Oxide as a Modulator of Insulin Action

  1997cited by this paper
• Nitric Oxide Stimulates Skeletal Muscle Glucose Transport Through a Calcium/Contraction– and Phosphatidylinositol-3-Kinase–Independent Pathway

  1997cited by this paper
• Exercise-stimulated glucose transport in skeletal muscle is nitric oxide dependent.

  1997cited by this paper
• The Coupling of Glucose Metabolism and Perfusion in Human Skeletal Muscle: The Potential Role of Endothelium-Derived Nitric Oxide

  1996cited by this paper
• Immunolocalization of Bradykinin B2 Receptors on Skeletal Muscle Cells

  1996cited by this paper
• Potential Role of Bradykinin in Forearm Muscle Metabolism in Humans

  1996cited by this paper
• Effects of Treatment of Spontaneously Hypertensive Rats With the Angiotensin-Converting Enzyme Inhibitor Trandolapril and the Calcium Antagonist Verapamil on the Sensitivity of Glucose Metabolism to Insulin in Rat Soleus Muscle In Vitro

  1996cited by this paper
• Effects of trandolapril and verapamil on glucose transport in insulin-resistant rat skeletal muscle.

  1996cited by this paper
• Nitric oxide release in rat skeletal muscle capillary.

  1996cited by this paper
• Antihypertensive therapy with enalapril improves glucose storage and insulin sensitivity in hypertensive patients with non-insulin-dependent diabetes mellitus.

  1995cited by this paper
• Effects of captopril on glucose transport activity in skeletal muscle of obese Zucker rats.

  1995influential reference
• Insulin action and the insulin signaling network.

  1995cited by this paper
• Nitric oxide release is present from incubated skeletal muscle preparations.

  1994cited by this paper
• Suitability of 2-deoxyglucose for in vitro measurement of glucose transport activity in skeletal muscle.

  1994cited by this paper
• Effect on insulin sensitivity of angiotensin converting enzyme inhibitors with or without a sulphydryl group: Bradykinin may improve insulin resistance in dogs and humans

  1994cited by this paper
• Effect of soleus unweighting on stimulation of insulin-independent glucose transport activity.

  1993influential reference
• Glucose transporters and glucose transport in skeletal muscles of 1- to 25-mo-old rats.

  1993cited by this paper
• ACE inhibition improves insulin-sensitivity in aged insulin-resistant hypertensive patients.

  1992cited by this paper
• ACE-inhibition increases hepatic and extrahepatic sensitivity to insulin in patients with Type 2 (non-insulin-dependent) diabetes mellitus and arterial hypertension

  1991cited by this paper
• Insulin Resistance: A Multifaceted Syndrome Responsible for NIDDM, Obesity, Hypertension, Dyslipidemia, and Atherosclerotic Cardiovascular Disease

  1991cited by this paper
• Insulin sensitivity and blood lipids during antihypertensive treatment with special reference to ACE inhibition.

  1990cited by this paper
• Captopril enhances insulin responsiveness of forearm muscle tissue in non‐insulin‐dependent diabetes mellitus

  1987cited by this paper
• Modulation of the action of insulin in relation to the energy state in skeletal muscle tissue: possible involvement of kinins and prostaglandins.

  1982cited by this paper
• A dipeptidyl carboxypeptidase that converts angiotensin I and inactivates bradykinin.

  1970cited by this paper

• Kinin receptors in adipose tissue: drivers of inflammation and metabolic dysfunction in obesity

  2025cites this paper
• Uric acid and metabolic syndrome: Importance of hyperuricemia cut-off.

  2024cites this paper
• Hypertension in Patients with Insulin Resistance: Etiopathogenesis and Management in Children

  2022cites this paper
• Renin-Angiotensin System Blockade Is Associated with Exercise Capacity, Sympathetic Activity, and Endothelial Function in Patients with Chronic Kidney Disease

  2021cites this paper
• Modulation of insulin resistance by renin angiotensin system inhibitors: implications for cardiovascular prevention.

  2021cites this paper
• ACE2 and energy metabolism: the connection between COVID-19 and chronic metabolic disorders.

  2021cites this paper
• Bradykinin B2 Receptor Signaling Increases Glucose Uptake and Oxidation: Evidence and Open Questions

  2020cites this paper
• Comparison between calcium channel blocker with angiotensin converting enzyme inhibitor or angiotensin II type 1 receptor blocker combination on the development of new-onset diabetes in hypertensive Korean patients

  2020cites this paper
• An eBook on Type 2 Diabetes

  2018cites this paper
• Beta secretase regulation and inflammation in pancreatic β-cells: the potential role of Rooibos

  2018cites this paper
• The Vasculature in Prediabetes.

  2018cites this paper
• Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers for Prevention of Type 2 Diabetes

  2016cites this paper
• Relationship of Bradykinin B2 Receptor Gene C-58T Variation with Total-Cholesterol and Glucose in Essential Hypertension

  2016cites this paper
• Angiotensin-II blockage, muscle strength, and exercise capacity in physically independent older adults

  2016cites this paper
• Renal Denervation Reverses Hepatic Insulin Resistance Induced by High-Fat Diet

  2016cites this paper
• insulin action in rat skeletal muscle Effects of exercise training and ACE inhibition on

  2015cites this paper
• Antihypertensive agents in systemic hypertension associated with Type 2 diabetes in a tertiary care hospital

  2015cites this paper
• Potential Vascular Mechanisms of Ramipril Induced Increases in Walking Ability in Patients With Intermittent Claudication

  2014cites this paper
• Tissue kallikrein deficiency, insulin resistance, and diabetes in mouse and man.

  2014cites this paper
• CK-MM gene polymorphism does not influence the blood CK activity levels after exhaustive eccentric exercise

  2014cites this paper
• Genetic aspects of exercise and rhabdomyolysis.

  2014cites this paper
• A vascular mechanism for high-sodium-induced insulin resistance in rats

  2014cites this paper
• Non-canonical signalling and roles of the vasoactive peptides angiotensins and kinins.

  2014cites this paper
• Renin-Angiotensin System Blockers Protect Pancreatic Islets against Diet-Induced Obesity and Insulin Resistance in Mice

  2013cites this paper
• The role of the renin-angiotensin system in the development of insulin resistance in skeletal muscle.

  2013cites this paper
• The -9 /+9 Polymorphism of the Bradykinin Receptor Beta 2 Gene and Athlete Status: A Study Involving Two European Cohorts

  2013cites this paper
• The Role of the Angiotensin System in Cardiac Glucose Homeostasis

  2012cites this paper
• Prevention of Type 2 Diabetes Mellitus Through Inhibition of the Renin-Angiotensin System

  2012cites this paper
• Diabetic cardiomyopathy: ongoing controversies in 2012

  2012cites this paper
• The Renin-Angiotensin System in the Pathophysiology of Type 2 Diabetes

  2012cites this paper
• Effect of Inhibition of Angiotensin-Converting Enzyme and/or Neutral Endopeptidase on Neuropathy in High-Fat-Fed C57Bl/6J Mice

  2012cites this paper
• Microvascular dysfunction and the development of muscle insulin resistance

  2012influential citation
• Mechanisms for the sustained effects of prior exercise on AS160 phosphorylation and insulin-stimulated glucose transport in rodent skeletal muscle

  2012cites this paper
• Rassegneinibitori dell'enzima di conversione dell'angiotensina: da farmaci vasoattivi a strumento di prevenzione cardiovascolare

  2012cites this paper
• ACE Inhibitors and Angiotensin Receptor Antagonists and the Incidence of New-Onset Diabetes Mellitus

  2012cites this paper
• Angiotensin‐converting enzyme inhibition increases glucose‐induced insulin secretion in response to acute restraint

  2012cites this paper
• Diabetic cardiomyopathy: understanding the molecular and cellular basis to progress in diagnosis and treatment

  2012cites this paper
• The Role of Angiotensin II in Skeletal Muscle Metabolism

  2011cites this paper
• Diabetes Mellitus tipo 2: Aspectos fisiológicos, genéticos e formas de exercício físico para seu controle

  2011cites this paper
• Postexercise skeletal muscle glucose transport is normal in kininogen-deficient rats.

  2011cites this paper
• The B2 receptor of bradykinin is not essential for the post-exercise increase in glucose uptake by insulin-stimulated mouse skeletal muscle.

  2011cites this paper
• STARR (STudy of Atherosclerosis with Ramipril and Rosiglitazone) People With Impaired Glucose Tolerance or Impaired Fasting Glucose: Effect of Ramipril and of Rosiglitazone on Carotid Intima-Media Thickness in

  2011cites this paper
• Angiotensin-converting enzyme inhibition changes the metabolic response to neuroglucopenic stress

  2011cites this paper
• Angiotensin converting enzyme and mitochondria – molecular and genetic mechanisms involving bradykinin receptors and uncoupling proteins

  2010cites this paper
• CK-MM Gene Polymorphism Does not Influence the Blood CK Activity Levels After Exhaustive Eccentric Exercise

  2010cites this paper
• The B 2 receptor of bradykinin is not essential for the post-exercise increase in glucose uptake by insulin-stimulated mouse skeletal muscle

  2010cites this paper
• Treatment of diabetic vasculopathy with rosiglitazone and ramipril: Hype or hope?

  2009cites this paper
• Análisis molecular y modificadores fenotípicos de la enfermedad de McArdle

  2009cites this paper
• Chalcones: Differential effects on glycogen contents of liver, brain and spinal cord in rats

  2009cites this paper
• Elevated expression of urotensin II and its receptor in skeletal muscle of diabetic mouse.

  2009cites this paper
• Effect of ramipril and of rosiglitazone on carotid intima-media thickness in people with impaired glucose tolerance or impaired fasting glucose: STARR (STudy of Atherosclerosis with Ramipril and Rosiglitazone).

  2009cites this paper
• The sweeter side of ACE2: Physiological evidence for a role in diabetes

  2008cites this paper
• Role of the renin-angiotensin system in age-related sarcopenia and diastolic dysfunction.

  2008cites this paper
• Treating hypertension while protecting the vulnerable islet in the cardiometabolic syndrome.

  2008cites this paper
• Blocking the renin-angiotensin-aldosterone system to prevent diabetes mellitus

  2008cites this paper
• Genetically altered animals in the study of the metabolic functions of peptide hormone systems

  2008cites this paper
• Protection of pancreatic beta-cells: is it feasible?

  2008cites this paper
• Angiotensin receptor blockers: novel role in high-risk patients.

  2008cites this paper
• Obesity, Insulin Resistance, and Microvessel Density

  2007cites this paper
• Obesity cardiomyopathy: diagnosis and therapeutic implications

  2007cites this paper
• Mechanisms of protective effects induced by blockade of the renin–angiotensin system: novel role of the pancreatic islet angiotensin‐generating system in Type 2 diabetes

  2007cites this paper
• ACE ID genotype affects blood creatine kinase response to eccentric exercise.

  2007cites this paper
• The I allele of the ACE gene is associated with improved exercise capacity in women with McArdle disease

  2007cites this paper
• The effect of antihypertensive drugs and drug combinations on the incidence of new‐onset type‐2 diabetes mellitus

  2007cites this paper
• Genotype modulators of clinical severity in McArdle disease.

  2007cites this paper
• THE SKELETAL MUSCLE RAS IN HEALTH AND DISEASE

  2007cites this paper
• ACE Inhibition in Heart Failure and Ischaemic Heart Disease

  2007cites this paper
• Insulin resistance and hypertension: the link

  2007cites this paper
• The I allele of the ACE gene is associated with improved exercise capacity in women with McArdle disease

  2007cites this paper
• Reducing diabetes incidence through the inhibition of the renin–angiotensin system: a strategy for reducing cardiovascular mortality and morbidity?

  2007cites this paper
• Role of the kinin B1 receptor in insulin homeostasis and pancreatic islet function

  2006cites this paper
• New Onset of Type 2 Diabetes Mellitus during Antihypertensive Therapy

  2006cites this paper
• Effect of antihypertensive agents on the development of type 2 diabetes mellitus.

  2006cites this paper
• Bradykinin Augments Insulin-Stimulated Glucose Transport in Rat Adipocytes via Endothelial Nitric Oxide Synthase–Mediated Inhibition of Jun NH2-Terminal Kinase

  2006cites this paper
• Inhalation of Human Insulin (Exubera) Augments the Efficiency of Muscle Glucose Uptake In Vivo

  2006cites this paper
• Are Current Strategies to Control Diabetes Effective ?

  2005cites this paper
• Ramipril in the treatment of vascular diseases

  2005cites this paper
• The Effects of Enalapril Maleate and Cold Stress on Some Blood Parameters

  2005cites this paper
• Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for prevention of type 2 diabetes: a meta-analysis of randomized clinical trials.

  2005cites this paper
• Strategies to prevent type 2 diabetes

  2005cites this paper
• The cardiovascular continuum and renin–angiotensin–aldosterone system blockade

  2005cites this paper
• Angiotensin-converting enzyme inhibition intervention in elderly persons: effects on body composition and physical performance.

  2005cites this paper
• The Renin—Angiotensin System in Diabetic Cardiovascular Complications

  2005cites this paper
• Advanced-glycation end products in insulin-resistant states

  2005cites this paper
• Angiotensin-converting enzyme inhibition, body composition, and physical performance in aged rats.

  2004cites this paper
• Bradykinin (B2 independent effect of captopril on the development of pressure overload cardiac hypertrophy

  2004cites this paper
• Changes in Vascular Distensibility during Angiotensin-Converting Enzyme Inhibition Involve Bradykinin Type 2 Receptors

  2004cites this paper
• Putative roles of kinin receptors in the therapeutic effects of angiotensin 1-converting enzyme inhibitors in diabetes mellitus.

  2004cites this paper
• Renin-angiotensin system inhibition prevents type 2 diabetes mellitus. Part 2. Overview of physiological and biochemical mechanisms.

  2004cites this paper
• Mechanism of improving effect of losartan on insulin sensitivity of non-insulin-dependent diabetes mellitus rats.

  2004cites this paper
• Effect of imidapril, an angiotensin-converting enzyme inhibitor, on fructose-induced insulin resistance in rats.

  2004influential citation
• Renin-angiotensin system inhibition prevents type 2 diabetes mellitus. Part 2. Overview of physiological and biochemical mechanisms L'inhibition du système rénine angiotensine prévient le diabète de type 2. Partie 2. Analyse des mécanismes physiologiques et biochimiques

  2004cites this paper
• Pharmacoepidemiology and disability in older adults: can medications slow the age-related decline in physical function?

  2004cites this paper
• The kallikrein‐kinin system, angiotensin converting enzyme inhibitors and insulin sensitivity

  2004cites this paper
• BENEFITS OF RENIN ANGIOTENSIN SYSTEM INHIBITORS IN HYPERTENSIVE PATIENTS WITH DIABETES MELLITUS

  2004cites this paper
• Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications.

  2004cites this paper
• ACE Inhibition with Moexipril

  2003cites this paper
• ACE inhibition may decrease diabetes risk by boosting the impact of bradykinin on adipocytes.

  2003cites this paper
• Enalapril Reduces the Incidence of Diabetes in Patients With Chronic Heart Failure: Insight From the Studies Of Left Ventricular Dysfunction (SOLVD)

  2003cites this paper
• Modulation of metabolic control by angiotensin converting enzyme (ACE) inhibition

  2003cites this paper